Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- Section II Botulinum Toxin Therapy
- 21 The Global Market for Botulinum Toxin
- 22 Molecular Mechanisms of Botulinum Toxin
- 23 Indirect Central Nervous System Effects of Botulinum Toxin
- 24 Direct Central Nervous System Effects of Botulinum Neurotoxin
- 25 Analgesic Effects of Botulinum Toxins
- 26 Manufacture of Commercial Botulinum Neurotoxins for Human Treatment
- 27 Pharmacology of Botulinum Toxins
- 28 Immunology of Botulinum Toxin Therapy
- 29 Use of Non-A/Non-B Botulinum Toxins
- 30 Clinical Muscular Anatomy for the Botulinum Toxin Injector
- 31 Ultrasound Guidance for Botulinum Toxin Application
- 32 Treatment Algorithms and Injection Schemes for Botulinum Toxin Therapy of Dystonia
- 33 Botulinum Toxin Therapy for Cervical Dystonia
- 34 Botulinum Toxin Therapy for Cranial Dystonia
- 35 Botulinum Toxin Therapy for Spasmodic Dysphonia
- 36 Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
- 37 Botulinum Toxin Therapy for Bruxism
- 38 Treatment of Blepharospasm With Eyelid-Opening Apraxia
- 39 Organisation of a Botulinum Toxin Clinic
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
22 - Molecular Mechanisms of Botulinum Toxin
from Section II - Botulinum Toxin Therapy
Published online by Cambridge University Press: 31 May 2018
Book contents
- Treatment of Dystonia
- Treatment of Dystonia
- Copyright page
- Contents
- Contributors
- Preface
- 1 Development of the Concept of Dystonia as a Disease, a Syndrome and a Movement Phenomenology
- Section I Basics
- Section II Botulinum Toxin Therapy
- 21 The Global Market for Botulinum Toxin
- 22 Molecular Mechanisms of Botulinum Toxin
- 23 Indirect Central Nervous System Effects of Botulinum Toxin
- 24 Direct Central Nervous System Effects of Botulinum Neurotoxin
- 25 Analgesic Effects of Botulinum Toxins
- 26 Manufacture of Commercial Botulinum Neurotoxins for Human Treatment
- 27 Pharmacology of Botulinum Toxins
- 28 Immunology of Botulinum Toxin Therapy
- 29 Use of Non-A/Non-B Botulinum Toxins
- 30 Clinical Muscular Anatomy for the Botulinum Toxin Injector
- 31 Ultrasound Guidance for Botulinum Toxin Application
- 32 Treatment Algorithms and Injection Schemes for Botulinum Toxin Therapy of Dystonia
- 33 Botulinum Toxin Therapy for Cervical Dystonia
- 34 Botulinum Toxin Therapy for Cranial Dystonia
- 35 Botulinum Toxin Therapy for Spasmodic Dysphonia
- 36 Botulinum Toxin Therapy for Writer’s Cramp and Other Focal Hand Dystonias
- 37 Botulinum Toxin Therapy for Bruxism
- 38 Treatment of Blepharospasm With Eyelid-Opening Apraxia
- 39 Organisation of a Botulinum Toxin Clinic
- Section III Musician’s Dystonia
- Section IV Psychogenic Dystonia
- Section V Treatment of Paediatric Dystonia
- Section VI Rehabilitation of Dystonia
- Section VII Pharmacotherapy for Dystonia
- Section VIII Surgical Treatment of Dystonia
- Section IX Deep Brain Stimulation for Dystonia
- Section X Emerging Therapies for Dystonia
- Section XI Future Trends in Dystonia Therapy
- Book part
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Treatment of Dystonia , pp. 102 - 105Publisher: Cambridge University PressPrint publication year: 2018
References
Antonucci, F, Rossi, C, Gianfranceschi, L, Rossetto, O, Caleo, M (2008) Long-distance retrograde effects of botulinum neurotoxin. A J Neurosci 28:3689–96.Google Scholar
Binz, T (2013) Clostridial neurotoxin light chains: devices for SNARE cleavage mediated blockade of neurotransmission. Curr Top Microbiol Immunol 364:139–157.Google Scholar
Binz, T, Rummel, A (2009) Cell entry strategy of clostridial neurotoxins. J Neurochem 109:1584–1595.Google Scholar
Colasante, C, Rossetto, O, Morbiato, L, Pirazzini, M, Molgó, J, Montecucco, C (2013) Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction. Mol Neurobiol 48:120–127.CrossRefGoogle ScholarPubMed
Eisele, KH, Fink, K, Vey, M, Taylor, HV (2011) Studies on the dissociation of botulinum neurotoxin type A complexes. Toxicon 57:555–565.Google Scholar
Eleopra, R, Tugnoli, V, Quatrale, R, Rossetto, O, Montecucco, C (2004) Different types of botulinum toxin in humans. Mov Disord 8:S53–S59.Google Scholar
Fischer, A, Montal, M (2007) Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J Biol Chem 282: 29604–29611.Google Scholar
Gu, S, Rumpel, S, Zhou, J, Strotmeier, J, Bigalke, H, Perry, K, Shoemaker, CB, Rummel, A, Jin, R (2012) Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science 335:977–981.Google Scholar
Hill, KK, Smith, TJ (2013) Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr Top Microbiol Immunol 364:1–20.Google Scholar
Hughes, R, Whaler, BC (1962) Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin. J Physiol 160:221–233.CrossRefGoogle ScholarPubMed
Lacy, DB, Tepp, W, Cohen, A, DasGupta, BR, Stevens, RC (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5:898–902.Google Scholar
Lee, K, Gu, S, Jin, L, Le, TT, Cheng, LW, Strotmeier, J, Kruel, AM, Yao, G, Perry, K, Rummel, A, Jin, R (2013) Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog 9:e1003690.Google Scholar
Masuyer, G, Chaddock, JA, Foster, KA, Acharya, KR (2014) Engineered botulinum neurotoxins as new therapeutics. Annu Rev Pharmacol Toxicol 54: 27–51.Google Scholar
Mazzocchio, R, Caleo, M (2015) More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system. Neuroscientist 21:44–61.Google Scholar
Montal, M (2010) Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem 79:591–617.Google Scholar
Montecucco, C (1986) How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci 11:314–317.CrossRefGoogle Scholar
Montecucco, C, Rasotto, MB (2015) On botulinum neurotoxin variability. MBio 6:e02131-14.Google Scholar
Pantano, S, Montecucco, C (2014) The blockade of the neurotransmitter release apparatus by botulinum neurotoxins. Cell Mol Life Sci 71:793–811.Google Scholar
Pellett, S, Tepp, WH, Whitemarsh, RC, Bradshaw, M, Johnson, EA (2015) In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1–5. Toxicon 107(Pt A):37–42.Google Scholar
Pirazzini, M, Bordin, F, Rossetto, O, Shone, CC, Binz, T, Montecucco, C (2013) The thioredoxin reductase–thioredoxin system is involved in the entry of tetanus and botulinum neurotoxins in the cytosol of nerve terminals. FEBS Lett 587:150–155.Google Scholar
Pirazzini, M, Azarnia Tehran, D, Zanetti, G, Megighian, A, Scorzeto, M, Fillo, S, Shone, CC, Binz, T, Rossetto, O, Lista, F, Montecucco, C (2014) Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins. Cell Rep 8:1870–1878.Google Scholar
Pirazzini, M, Azarnia Tehran, D, Leka, O, Zanetti, G, Rossetto, O, Montecucco, C (2016) On the translocation of botulinum and tetanus neurotoxins across the membrane of acidic intracellular compartments. Biochim Biophys Acta 1858:467–474.Google Scholar
Restani, L, Giribaldi, F, Manich, M, Bercsenyi, K, Menendez, G, Rossetto, O, Caleo, M, Schiavo, G (2012) Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons. PLoS Pathog 8:e1003087.CrossRefGoogle Scholar
Rossetto, O, Pirazzini, M, Montecucco, C (2014) Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol 12:535–549.Google Scholar
Rossetto, O, Pirazzini, M, Montecucco, C (2015) Current gaps in basic science knowledge of botulinum neurotoxin biological actions. Toxicon 107(Pt A):59–63.Google Scholar
Rummel, A (2013) Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 364:61–90.Google Scholar
Smith, LD, Sugiyama, H (1988) Botulism: The Organism, its Toxins, the Disease. Springfield, IL: C.C. Thomas Publisher.Google Scholar